ORAFID Trademark

Trademark Overview

On Friday, October 21, 2022, a trademark application was filed for ORAFID with the United States Patent and Trademark Office. The USPTO has given the ORAFID trademark a serial number of 79358812. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by Sensidose Aktiebolag. The ORAFID trademark is filed in the Medical Instrument Products category with the following description:

Apparatus, namely multi-dosage dispensers for drug administration
orafid

General Information

Serial Number79358812
Word MarkORAFID
Filing DateFriday, October 21, 2022
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7307418
Registration DateTuesday, February 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements

Goods and ServicesApparatus, namely multi-dosage dispensers for drug administration

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSensidose Aktiebolag
Party Type30 - Original Registrant
Legal Entity Type64 - NOT AVAILABLE
AddressSE
Party NameSensidose Aktiebolag
Party Type20 - Owner at Publication
Legal Entity Type64 - NOT AVAILABLE
AddressSE
Party NameSensidose Aktiebolag
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSE

Trademark Events

Event DateEvent Description
Monday, August 7, 2023ASSIGNED TO EXAMINER
Thursday, December 29, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, January 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 7, 2023APPLICATION FILING RECEIPT MAILED
Friday, August 11, 2023NON-FINAL ACTION WRITTEN
Saturday, August 12, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 1, 2023REFUSAL PROCESSED BY MPU
Friday, September 1, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, September 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 25, 2023REFUSAL PROCESSED BY IB
Monday, October 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, November 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, December 3, 2023NOTIFICATION PROCESSED BY IB
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 15, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, November 30, 2023ASSIGNED TO EXAMINER
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, July 17, 2024FINAL DISPOSITION NOTICE SENT TO IB
Sunday, August 4, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 17, 2024FINAL DISPOSITION PROCESSED

Related Keywords

orafid drug administration dispensers dosage namely multi apparatus